Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Select Nautilus presentations from HUPO 2024

Key Takeaway: Nautilus Biotechnology presented two key talks at HUPO 2024 in Dresden, Germany. The first, by Andreas Huhmer, focused on quantitative assessments of tau proteoforms using the Nautilus Proteome Analysis Platform. The second presentation by Sheri Wilcox highlighted the platform's capability to achieve a wide dynamic range for comprehensive proteome coverage.
Price reaction · baseline $2.715 (2024-11-07T16:13:00.000Z) · hit during market hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentations showcase innovative proteome analysis techniques.
  • Demonstrated ability to measure tau proteoforms with high resolution.
  • Nautilus platform designed for comprehensive proteome coverage.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Research and Collaborations
Nautilus Biotechnology
November 7, 2024
Below we share recordings of two presentations from our time at HUPO 2024 in Dresden, Germany. The first presentation is by Nautilus Senior Director of Scientific Affairs and Alliance Management Andreas Huhmer and covers how we conduct quantitative assessments of tau proteoforms on the Nautilus Proteome Analysis Platform. The second presentation is by Nautilus VP of Probe Development and Bioinformatics Sheri Wilcox and covers how the platform is designed to achieve a wide dynamic range enabling comprehensive proteome coverage. Have any questions for us? Reach out via our contact page .

Quantitative assessment of Tau proteoform changes in iPSC-derived neurons during differentiation

Senior Director of Scientific Affairs and Alliance Management Andreas Huhmer presents new data demonstrating the Nautilus Proteome Analysis Platform’s ability to measure tau proteoforms in various biological models.
Click on the button to the right and fill out the form to learn how we measure tau proteoforms with an unprecedented level of resolution.

Sensitivity and dynamic range of massively parallel single-molecule protein quantitation using PrISM

VP of Probe Development and Bioinformatics Sheri Wilcox shares how the Nautilus Proteome Analysis Platform is designed to quantify proteins across the wide dynamic range of the proteome and quantify substantively the entire proteome.
Click on the button to the right and fill out the form to learn how our proteome quantification methodology known as Protein identification by Short-epitope Mapping (PrISM) enables comprehensive proteome coverage.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics could unlock how tau protein and Alzheimer’s are linked
Learn about the links between tau and Alzheimer's and find out how we're using the Nautilus platform to better understand their connections.
Read more
Nautilus at US HUPO 2025 – Bringing the proteome into focus with the Nautilus Proteome Analysis Platform
Learn about the latest data generated by the Nautilus Platform and shared at US HUPO 2025.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What was presented by Andreas Huhmer?

Andreas Huhmer presented on quantitative assessments of tau proteoforms.

Who is Sheri Wilcox?

Sheri Wilcox is the VP of Probe Development and Bioinformatics at Nautilus.

What is the Nautilus Proteome Analysis Platform?

It is designed to achieve comprehensive proteome coverage and quantify proteins.

Where did Nautilus present their findings?

Nautilus presented at HUPO 2024 in Dresden, Germany.

Last updated: Nov 7, 2024